APA (7th ed.) Citation

Zschäbitz, S., Biernath, N., Hilser, T. K. J. W., Höllein, A., Zengerling, F. H., Cascucelli, J., . . . Darr, C. (2023). Enfortumab vedotin in metastatic urothelial carcinoma: Survival and safety in a European multicenter real-world patient cohort. European urology open science, 53, . https://doi.org/10.1016/j.euros.2023.04.018

Chicago Style (17th ed.) Citation

Zschäbitz, Stefanie, et al. "Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort." European Urology Open Science 53 (2023). https://doi.org/10.1016/j.euros.2023.04.018.

MLA (9th ed.) Citation

Zschäbitz, Stefanie, et al. "Enfortumab Vedotin in Metastatic Urothelial Carcinoma: Survival and Safety in a European Multicenter Real-world Patient Cohort." European Urology Open Science, vol. 53, 2023, https://doi.org/10.1016/j.euros.2023.04.018.